About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2012 (2012), Article ID 560345, 6 pages
http://dx.doi.org/10.1155/2012/560345
Research Article

Establishment of a Standardized Liver Fibrosis Model with Different Pathological Stages in Rats

1Ganmei Hospital, Kunming Medical University, Kunming 650000, China
2The Second Affiliated Hospital, Kunming Medical University, Kunming 650000, China
3Molecular Epidemiology Joint Laboratory, Institute of Medical Biology, Kunming 650000, China

Received 1 February 2012; Revised 5 April 2012; Accepted 19 April 2012

Academic Editor: Edoardo G. Giannini

Copyright © 2012 Li Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Dioguardi, F. Grizzi, P. Bossi, and M. Roncalli, “Fractal and spectral dimension analysis of liver fibrosis in needle biopsy specimens,” Analytical and Quantitative Cytology and Histology, vol. 21, no. 3, pp. 262–266, 1999. View at Scopus
  2. J. Kozłowska, T. Łoch, J. Jabłońska, and J. Cianciara, “Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin,” Przeglad Epidemiologiczny, vol. 55, no. 4, pp. 451–458, 2001. View at Scopus
  3. P. E. Chang, H. F. Lui, Y. P. Chau et al., “Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index,” Alimentary Pharmacology and Therapeutics, vol. 28, no. 1, pp. 51–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Paggi, A. Colli, M. Fraquelli et al., “A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: a comparison using histology with internal-external validation,” Journal of Hepatology, vol. 49, no. 4, pp. 564–571, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. E. M. Zardi, D. Aldo, A. Giovanni, M. Domenico, P. Francesco, and A. Antonella, “New therapeutic approaches to liver fibrosis: a practicable route?” Current Medicinal Chemistry, vol. 15, no. 16, pp. 1628–1644, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. G. D. Kirk, J. Astemborski, S. H. Mehta et al., “Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection,” Clinical Infectious Diseases, vol. 48, no. 7, pp. 963–972, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. G. Tiniakos, “Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients,” Gastroenterologie Clinique et Biologique, vol. 33, no. 10-11, pp. 930–939, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Boursier, Y. Bacq, P. Halfon et al., “Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 1, pp. 28–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Calès, F. Lainé, J. Boursier et al., “Comparison of blood tests for liver fibrosis specific or not to NAFLD,” Journal of Hepatology, vol. 50, no. 1, pp. 165–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Tannapfel, H. Denk, H. P. Dienes et al., “Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease: grade 2 consensus-based guidelines,” Pathologe, vol. 31, no. 3, pp. 225–237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Ishak, A. Baptista, L. Bianchi et al., “Histological grading and staging of chronic hepatitis,” Journal of Hepatology, vol. 22, no. 6, pp. 696–699, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Davoust, M. Boni, D. Branquet, J. Ducos de Lahitte, and G. Martet, “Research for three parasitic infections within a population of rats trapped in Marseille: evaluation of the zoonotic risk,” Bulletin de l'Academie Nationale de Medecine, vol. 181, no. 5, pp. 887–897, 1997. View at Scopus
  13. I. Maida, V. Soriano, P. Barreiro, P. Rivas, P. Labarga, and M. Núñez, “Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases,” AIDS Research and Human Retroviruses, vol. 23, no. 6, pp. 801–804, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Cuomo, A. Perrella, D. Pisaniello, G. Marino, and G. Di Costanzo, “Evidence of liver histological alterations in apparently healthy individuals evaluated for living donor liver transplantation,” Transplantation Proceedings, vol. 40, no. 6, pp. 1823–1826, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Woźniakowska-Gesicka, M. Wiśniewska-Ligier, J. Kupś, and A. Kałuzyński, “Histological evaluation of activity and progression changes in the liver in HCV infected children,” Polski Merkuriusz Lekarski, vol. 8, no. 48, pp. 381–383, 2000. View at Scopus
  16. W. H. Schraut, A. S. Rosemurgy, and R. M. Riddell, “Prolongation of intestinal allograft survival without immunosuppressive drug therapy. Transplantation of small bowel allografts,” Journal of Surgical Research, vol. 34, no. 6, pp. 597–607, 1983. View at Scopus
  17. M. A. M. Berends, M. G. H. Van Oijen, J. Snoek et al., “Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens,” Archives of Dermatology, vol. 143, no. 12, pp. 1515–1519, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Zen, T. Fujii, Y. Sato, S. Masuda, and Y. Nakanuma, “Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease,” Modern Pathology, vol. 20, no. 8, pp. 884–894, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Denk, “Chronic hepatitis,” Verhandlungen der Deutschen Gesellschaft für Pathologie, vol. 79, pp. 171–176, 1995.
  20. S. R. Kim, Y. Maekawa, S. Imoto, M. Sugano, and M. Kudo, “Hypervascular liver nodules in heavy drinkers of alcohol,” Alcoholism, vol. 28, supplement 2, pp. 174S–180S, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. G. P. Lee, W. I. Jeong, D. H. Jeong, S. H. Do, T. H. Kim, and K. S. Jeong, “Diagnostic evaluation of carbon tetrachloride-induced rat hepatic cirrhosis model,” Anticancer Research, vol. 25, no. 2A, pp. 1029–1038, 2005. View at Scopus
  22. A. Pariente, “How to measure liver fibrosis in viral hepatitis?” Revue du Praticien, vol. 55, no. 6, pp. 646–649, 2005. View at Scopus
  23. T. Sanzen, K. Harada, M. Yasoshima, Y. Kawamura, M. Ishibashi, and Y. Nakanuma, “Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis,” American Journal of Pathology, vol. 158, no. 5, pp. 1605–1612, 2001. View at Scopus
  24. G. Bettini, L. Mandrioli, and M. Morini, “Bile duct dysplasia and congenital hepatic fibrosis associated with polycystic kidney (Caroli syndrome) in a rat,” Veterinary Pathology, vol. 40, no. 6, pp. 693–694, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. F. S. Gao, B. Liu, Y. T. Zhan et al., “The changes of advanced glycation end products in a rat liver fibrosis model and the interventional effect of aminoguanidin,” Zhonghua Gan Zang Bing Za Zhi, vol. 14, no. 3, pp. 178–182, 2006. View at Scopus
  26. Z. A. Andrade and T. S. Santana, “Angiogenesis and schistosomiasis,” Memorias do Instituto Oswaldo Cruz, vol. 105, no. 4, pp. 436–439, 2010. View at Scopus
  27. M. E. Guicciardi and G. J. Gores, “Apoptosis as a mechanism for liver disease progression,” Seminars in Liver Disease, vol. 30, no. 4, pp. 402–410, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. W. C. Yeh, S. W. Huang, and P. C. Li, “Liver fibrosis grade classification with B-mode ultrasound,” Ultrasound in Medicine and Biology, vol. 29, no. 9, pp. 1229–1235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Uno, S. Kurita, H. Misu et al., “Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis,” Hepatology, vol. 48, no. 1, pp. 109–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. P. H. Tsui, C. C. Chang, M. C. Ho et al., “Use of nakagami statistics and empirical mode decomposition for ultrasound tissue characterization by a nonfocused transducer,” Ultrasound in Medicine and Biology, vol. 35, no. 12, pp. 2055–2068, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Tran-Paterson, D. Davin, R. D. Krauss, T. A. Rado, and D. M. Miller, “Expression and regulation of the cystic fibrosis gene during rat liver regeneration,” American Journal of Physiology, vol. 263, no. 1, pp. C55–C60, 1992. View at Scopus
  32. Y. Gnainsky, G. Spira, M. Paizi et al., “Involvement of the tyrosine phosphatase early gene of liver regeneration (PRL-1) in cell cycle and in liver regeneration and fibrosis effect of halofuginone,” Cell and Tissue Research, vol. 324, no. 3, pp. 385–394, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Zender, S. Hütker, C. Liedtke et al., “Caspase 8 small interfering RNA prevents acute liver failure in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 7797–7802, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. S. L. Friedman, “Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver,” Physiological Reviews, vol. 88, no. 1, pp. 125–172, 2008. View at Publisher · View at Google Scholar · View at Scopus